GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
137.10
-0.37 (-0.27%)
Oct 29, 2025, 1:17 PM EDT - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.96 billion as of October 29, 2025. Its market cap has increased by 145.07% in one year.
Market Cap
3.96B
Enterprise Value
3.93B
1-Year Change
145.07%
Ranking
Category
Stock Price
$137.10
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.96B, a decrease of -77.87%. That is a compound annual growth rate of -26.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 3.97B | 88.09% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | 17.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 450.37B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |